Translational PsychiatryGeneticsPeer-reviewed journal article
Novel genome-wide associations for anhedonia, genetic correlation with psychiatric disorders, and polygenic association with brain structure.
Joey WardiD, Laura M. LyalliD, Richard A. I. BethlehemiD, Amy FergusoniD, Rona J. StrawbridgeiD, Donald M. LyalliD, Breda CulleniD, Nicholas GrahamiD, Keira J.A. JohnstoniD, Mark E.S. BaileyiD, Graham K. MurrayiD, Daniel J. SmıthiD
Abstract
Anhedonia is a core feature of several psychiatric disorders but its biological underpinnings are poorly understood. We performed a genome-wide association study of anhedonia in 375,275 UK Biobank participants and assessed for genetic correlation between anhedonia and neuropsychiatric conditions (major depressive disorder, schizophrenia, bipolar disorder, obsessive compulsive disorder and Parkinsons Disease). We then used a polygenic risk score approach to test for association between genetic loading for anhedonia and both brain structure and brain function. This included: magnetic resonance imaging (MRI) assessments of total grey matter volume, white matter volume, cerebrospinal fluid volume, and 15 cortical/subcortical regions of interest; diffusion tensor imaging (DTI) measures of white matter tract integrity; and functional MRI activity during an emotion processing task. We identified 11 novel loci associated at genome-wide significance with anhedonia, with a SNP heritability estimate (h2SNP) of 5.6%. Strong positive genetic correlations were found between anhedonia and major depressive disorder, schizophrenia and bipolar disorder; but not with obsessive compulsive disorder or Parkinsons Disease. Polygenic risk for anhedonia was associated with poorer brain white matter integrity, smaller total grey matter volume, and smaller volumes of brain regions linked to reward and pleasure processing, including nucleus accumbens, caudate and medial frontal cortex. In summary, the identification of novel anhedonia-associated loci substantially expands our current understanding of the biological basis of anhedonia and genetic correlations with several psychiatric disorders confirm the utility of this trait as a transdiagnostic marker of vulnerability to mental illness. We also provide the first evidence that genetic risk for anhedonia influences brain structure, particularly in regions associated with reward and pleasure processing.
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 83
- FWCI
- 6.31
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genome-wide analysis of over 106,000 individuals identifies 9 neuroticism-associated loci
Daniel J Smith, Valentina Escott-Price, … Michael O'Donovan·bioRxiv·Jan 23, 2016
- Linking the genetic structure of neuroanatomical phenotypes with psychiatric disorders
Antoine Auvergne, Nicolas Traut, … Hugues Aschard·bioRxiv·Nov 1, 2023
- Genetic association study of psychotic experiences in UK Biobank
Sophie E. Legge, Hannah J Jones, … James Walters·JAMA PsychiatryPeer-reviewed·Sep 25, 2019
- Genetic underpinnings of sociability in the UK Biobank
Janita Bralten, C.J.H.M. Klemann, … Geert Poelmans·bioRxiv·Oct 23, 2019
- Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling
Nora I. Strom, Brad Verhulst, … Ted Reichborn‐Kjennerud·Nature GeneticsPeer-reviewed·Feb 1, 2026
- Genome-wide analysis in UK Biobank identifies four loci associated with mood instability and genetic correlation with major depressive disorder, anxiety disorder and schizophrenia.
Joey Ward, Rona J. Strawbridge, … Daniel J. Smıth·Translational PsychiatryPeer-reviewed·Nov 29, 2017